Literature DB >> 7740817

Gastritis in Barrett's esophagus.

R J Mason1, C G Bremner.   

Abstract

Duodenogastric reflux has been implicated in the pathogenesis of complicated Barrett's esophagus and gastric ulceration. A group of 123 Barrett's patients were followed for a mean of 41 months; 9 (7%) developed gastric ulceration (GU). Of the Barrett's patients treated by antireflux surgery, 14% developed GU. We reviewed the gastric histology on 54 Barrett's patients (34 men, 20 women; average age 64 years) at presentation and classified the gastritis according to the Sydney system. A normal histologic pattern was present in seven patients; 15 patients had chronic pangastritis, 9 chronic antral gastritis, and 18 chronic gastritis of the corpus. Five patients had acute gastritis only, and in 74% there was reactive chronic gastritis. Of the patients with chronic gastritis, 45% (19 of 42) had histologic evidence of duodenogastric reflux, established by the bile reflux index. The presence of reactive chronic gastritis in Barrett's patients may have important pathophysiologic and therapeutic implications.

Entities:  

Mesh:

Year:  1995        PMID: 7740817     DOI: 10.1007/BF00316987

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  27 in total

1.  Occurrence of gastric ulcer after Nissen fundoplication.

Authors:  F L Bushkin; E R Woodward; J P O'Leary
Journal:  Am Surg       Date:  1976-11       Impact factor: 0.688

Review 2.  Chronic gastritis and ulcer risk.

Authors:  P Sipponen
Journal:  Scand J Gastroenterol       Date:  1990-03       Impact factor: 2.423

3.  Surgical therapy in Barrett's esophagus.

Authors:  T R DeMeester; S E Attwood; T C Smyrk; D H Therkildsen; R A Hinder
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

4.  Gastric ulceration after fundic wrapping. Vagal nerve entrapment, a possible causative factor.

Authors:  J L Herrington; P W Meacham; R M Hunter
Journal:  Ann Surg       Date:  1982-05       Impact factor: 12.969

5.  The reversibility of postgastrectomy alkaline reflux gastritis by a Roux-en-Y loop.

Authors:  H H Lawson
Journal:  Br J Surg       Date:  1972-01       Impact factor: 6.939

6.  Association of infection due to Helicobacter pylori with specific upper gastrointestinal pathology.

Authors:  M J Blaser; G I Perez-Perez; J Lindenbaum; D Schneidman; G Van Deventer; M Marin-Sorensen; W M Weinstein
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

7.  Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori.

Authors:  A Di Napoli; R Petrino; M Boero; D Bellis; L Chiandussi
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

8.  Fundoplication for gastro-oesophageal reflux.

Authors:  I C O'Rourke
Journal:  Aust N Z J Surg       Date:  1985-08

9.  Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus.

Authors:  P Gillen; P Keeling; P J Byrne; M Healy; R R O'Moore; T P Hennessy
Journal:  Br J Surg       Date:  1988-06       Impact factor: 6.939

10.  Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis.

Authors:  H J O'Connor; M F Dixon; J I Wyatt; A T Axon; D C Ward; E P Dewar; D Johnston
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

View more
  3 in total

Review 1.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J A Jankowski; N A Wright; S J Meltzer; G Triadafilopoulos; K Geboes; A G Casson; D Kerr; L S Young
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

2.  Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?

Authors:  M F Dixon; P M Neville; N P Mapstone; P Moayyedi; A T Axon
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

3.  Gallstones increase the prevalence of Barrett's esophagus.

Authors:  Juntaro Matsuzaki; Hidekazu Suzuki; Keiko Asakura; Yoshimasa Saito; Kenro Hirata; Toru Takebayashi; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2009-11-12       Impact factor: 7.527

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.